[go: up one dir, main page]

AR111103A1 - Recipiente para sellado de formulaciones y uso del mismo - Google Patents

Recipiente para sellado de formulaciones y uso del mismo

Info

Publication number
AR111103A1
AR111103A1 ARP180100345A ARP180100345A AR111103A1 AR 111103 A1 AR111103 A1 AR 111103A1 AR P180100345 A ARP180100345 A AR P180100345A AR P180100345 A ARP180100345 A AR P180100345A AR 111103 A1 AR111103 A1 AR 111103A1
Authority
AR
Argentina
Prior art keywords
liquid formulation
container
same
sealing formulations
formulations
Prior art date
Application number
ARP180100345A
Other languages
English (en)
Inventor
Sudeep Rauser
Le An
Chun Chu
- Shiono Hiromitsu Jung
Kedar Datar
Sreenivasu Mudumba
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of AR111103A1 publication Critical patent/AR111103A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D1/00—Rigid or semi-rigid containers having bodies formed in one piece, e.g. by casting metallic material, by moulding plastics, by blowing vitreous material, by throwing ceramic material, by moulding pulped fibrous material or by deep-drawing operations performed on sheet material
    • B65D1/02—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents
    • B65D1/0223—Bottles or similar containers with necks or like restricted apertures, designed for pouring contents characterised by shape
    • B65D1/0261—Bottom construction
    • B65D1/0276—Bottom construction having a continuous contact surface, e.g. Champagne-type bottom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1412—Containers with closing means, e.g. caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/712—Containers; Packaging elements or accessories, Packages
    • B29L2031/7158—Bottles
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3216—Rigid containers disposed one within the other

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Ceramic Engineering (AREA)
  • Mechanical Engineering (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Recipiente para sellado de formulaciones que permite una estabilización a largo plazo de la rapamicina contenida en una formulación liquida, que incluye: el cuerpo del recipiente sellado en cuyo interior hay una formulación líquida que contiene 2% (p/p) de rapamicina o una sal de la misma, 94% (p/p) de polietilenglicol y 4% (p/p) de etanol, donde dicho cuerpo del recipiente sellado tiene un volumen de entre 0,1 ml y 1,0 ml, la formulación líquida no contiene un antioxidante y la formulación liquida tiene un volumen total de entre 0,02 ml y 1,0 ml.
ARP180100345A 2017-02-17 2018-02-14 Recipiente para sellado de formulaciones y uso del mismo AR111103A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762460654P 2017-02-17 2017-02-17

Publications (1)

Publication Number Publication Date
AR111103A1 true AR111103A1 (es) 2019-06-05

Family

ID=63169298

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180100345A AR111103A1 (es) 2017-02-17 2018-02-14 Recipiente para sellado de formulaciones y uso del mismo

Country Status (5)

Country Link
US (1) US11285081B2 (es)
JP (1) JP7092687B2 (es)
AR (1) AR111103A1 (es)
TW (1) TW201834638A (es)
WO (1) WO2018151143A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3199717A1 (en) * 2020-11-20 2022-05-27 Michael Bucholtz Polymer vials having standard external dimensions and reduced internal volume
CN118387436A (zh) * 2024-05-03 2024-07-26 长沙方今科技有限公司 一种微型玻璃容器及其制造方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4313932B2 (ja) * 2000-07-04 2009-08-12 株式会社大協精工 医薬品用有底筒状容器
GB2438544A (en) * 2005-02-09 2007-11-28 Cooper Internat Corp Liquid formulations for treatment of diseases or conditions
JP5528708B2 (ja) 2006-02-09 2014-06-25 参天製薬株式会社 安定な製剤ならびにそれらを調製および使用する方法
JP6459490B2 (ja) 2014-12-22 2019-01-30 株式会社島津製作所 バイアルインサート及びバイアルインサートシート

Also Published As

Publication number Publication date
TW201834638A (zh) 2018-10-01
JP7092687B2 (ja) 2022-06-28
US20190358128A1 (en) 2019-11-28
WO2018151143A1 (ja) 2018-08-23
JPWO2018151143A1 (ja) 2019-12-12
US11285081B2 (en) 2022-03-29

Similar Documents

Publication Publication Date Title
MX2022014517A (es) Cartucho para proporcionar un producto liquido, un sistema para proporcionar un producto liquido y un metodo que usa dicho sistema.
MX2017011039A (es) Dispositivo y metodo para realizar conexiones asepticas.
PH12016502041B1 (en) Strip package for antiseptic cap
MX2018000473A (es) Empaquetado de medicamentos.
MX2019003832A (es) Diseño y aplicación de un cartucho de multiples camaras que incluye una formulacion de hidrogel.
PH12017501324A1 (en) Vapour provision system and cartridge therefor
MX2014008698A (es) Vial de multiples dosis y metodos.
MX389375B (es) Recipiente suministrador de liquido con valvula de posicion multiple y popote.
AR093556A1 (es) Contenedor de un solo uso con dispensador
CL2015003266A1 (es) Formulación estabilizada de pemetrexed.
BR112016006983A8 (pt) Dispositivo para desinfecção de conectores de cateter
MX2016012684A (es) Recipiente de liberacion controlada.
PE20120247A1 (es) Jeringa de vidreo con aguja replegable
MX2019014671A (es) Contenedor con particulas para su uso con un inhalador.
WO2020231474A8 (en) Container and cap assembly for cryogenic storage
MX2016003054A (es) Tapa para un recipiente y recipiente, en particular un tubo, en particular un tubo flexible para un producto cosmetico, provisto de dicha tapa.
AR111834A1 (es) Composiciones líquidas estables de inoculantes que comprenden dodecano
MX2020009933A (es) Recipientes de envasado en atmósfera modificada.
MX2021002053A (es) Productos que contienen cannabinoides, contenedores, sistemas y métodos.
MX2018001790A (es) Articulo absorbente con cuerpo absorbente que proporciona mejor acceso a la bolsa de contencion del miembro de contencion de la cintura.
AR114324A1 (es) Péptidos de la cadena b de la relaxina lipidados modificados y su uso terapéutico
AR112103A1 (es) Compuestos para el tratamiento de tnbc
PH12018502615A1 (en) Depot formulations
CL2022000330A1 (es) Composición farmacéutica que contiene un agente antifúngico como ingrediente activo
MX2019008845A (es) Metodos y sistemas para mejorar la estabilidad de la formulacion prevapor de un dispositivo de vapeo electronico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure